ABSI Aug 2024 2.500 call
| Previous Close | 1.9500 |
| Open | 1.9500 |
| Bid | 1.8000 |
| Ask | 2.2000 |
| Strike | 2.50 |
| Expire Date | 2024-08-16 |
| Day's Range | 1.9500 - 1.9500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 200 |
GlobeNewswireAbsci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
VANCOUVER, Wash. and NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL. Absci management is scheduled to present on Monday, June 10th at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time). Interested parties may access a live and archived webcast on the company’s investor relations website
- GuruFocus.com
Absci Corp (ABSI) Q1 2024 Earnings Call Transcript Highlights: Strategic Advancements and ...
Explore key financial outcomes, strategic partnerships, and innovative developments from Absci Corp's first quarter of 2024.
- GlobeNewswire
Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
Initiated IND-enabling studies for ABS-101 in February Continuing to advance ABS-201 and ABS-301 through preclinical studies VANCOUVER, Wash. and NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today reported financial and operating results for the quarter ended March 31, 2024. "During the first quarter, we made significant strides in advancing both our internal and partnered programs according to plan," said Sean McC
